Article
Limited SHIV env diversification in macaques failing oral antiretroviral pre-exposure prophylaxis.
Retrovirology - 9 May 2012
Zheng Qi, Ruone Susan, Switzer William M, Heneine Walid, García-Lerma J Gerardo
Abstract excerpt
BACKGROUND: Pre-exposure prophylaxis (PrEP) with daily Truvada [a combination of emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF)] is a novel HIV prevention strategy recently found to prevent HIV transmission among men who have sex with men and heterosexual couples. Acute infection in adherent persons who fail PrEP will inevitably occur under concurrent antiretroviral therapy, thus raising questions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
